PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil

To report consensus recommendations on the current role of poly(ADP-ribose) polymerase (PARP) inhibitors in the front-line management of patients with epithelial ovarian cancer (EOC) in the healthcare setting of Brazil. The expert panel convened in March 2021 and comprised 20 medical oncologists foc...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aknar FC Calabrich, Daniele Xavier Assad, Graziela Dal-Molin, Andreia C Melo, Angelica Nogueira-Rodrigues, Karime Kalil, Andrea PG Guimarães, Michelle Samora Almeida, Carla Rameri de Azevedo, Daniela de Freitas, Alessandra Menezes Morelle, Ana Carolina Leite, Marcela Crosara, João Soares Nunes, Poliana Signorini, Eduardo Cronemberger, Rachel Cossetti, Rodrigo Guindalini, Eduardo Paulino, Fernando C Maluf
Format:	Artigo
Idioma:	Inglês
Publicat:	Thieme Revinter Publicações Ltda. 2023-04-01
Col·lecció:	Brazilian Journal of Oncology
Matèries:	carcinoma ovarian epithelial poly(adp-ribose) polymerase inhibitors consensus
Accés en línia:	https://www.brazilianjournalofoncology.com.br/details/238/en-US/parp-inhibitors-as-first-line-maintenance-therapy-in-ovarian-cancer--recommendations-from-an-expert-panel-from-brazil
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!